Get 40% Off
🚨 Volatile Markets? Find Hidden Gems for Serious Outperformance
Find Stocks Now

FTSE 100 starts November on front foot; central bank decisions in focus

Published 01/11/2023, 08:22
Updated 02/11/2023, 00:11
© Reuters. A man wearing a protective face mask walks past the London Stock Exchange Group building in the City of London financial district in London, Britain, March 9, 2020. REUTERS/Toby Melville/File Photo

By Khushi Singh and Siddarth S

(Reuters) -Britain's FTSE 100 started November on a positive footing, supported by retailer stocks, with Next shares leading gains on an upbeat profit outlook, while investors braced for a slew of central bank policy decisions.

The internationally-focused FTSE 100 ended 0.3% higher. The mid-cap FTSE 250 advanced 0.6%, logging its fourth consecutive day of gains.

Next Plc shares climbed 3.6% to the top of the FTSE 100 after the clothing retailer raised its annual profit outlook for the fourth time in six months.

The broader retailers index rose 1.6%.

Investors will be scrutinising the U.S. Federal Reserve's interest rate decision later in the day and the Bank of England's(BoE) monetary policy meeting on Thursday. Both central banks are widely expected to keep interest rates steady.

"I don't think anybody expects any change in the BoE's interest rates tomorrow, but they have got to be very careful with their messaging because the economy isn't particularly strong," said David Morrison, senior market analyst at Trade Nation.

On the data front, British house prices unexpectedly rose by almost 1% last month, mortgage lender Nationwide said, while UK's factories suffered a worse October than previously thought, according to a survey.

Automobiles and parts index fell 2.0% dragged down by a nearly 9% slump in Aston Martin shares after the luxury carmaker lowered its 2023 volume outlook.

GSK shares ended 2.4% down, after gaining earlier in the session, as the drugmaker raised its full-year profit and sales forecasts for a second time.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

"(GSK)shares gave up their early gains and slipped to the bottom of the FTSE 100 with some blaming underperformance from its Shingrix vaccine," Michael Hewson, chief market analyst at CMC Markets UK said in note.

Latest comments

Where?
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.